Article
CD33, CD96 and Death Associated Protein Kinase (DAPK) Expression Are Associated with the Survival Rate and/or Response to the Chemotherapy in the Patients with Acute Myeloid Leukemia (AML).
Medical science monitor : international medical journal of experimental and clinical research - 9 Apr 2017
Jiang Yongfang, Xu Ping, Yao Dandan, Chen Xi, Dai Haibin
Abstract excerpt
BACKGROUND Leukemia stem cells (LSC) are involved in the incidence, drug resistance, and relapse of leukemia while LSC-related antigen CD33, CD96, and DAPK expression in AML and its prognosis is still unclear. This study explored LSC-related antigens expression in acute myeloid leukemia (AML) and its prognosis. MATERIAL AND METHODS A total of 156 cases of AML patients were enrolled in the experiment. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.